Gilles Defraene
Papers
1
Total Citations
23
H-Index
1
About
Gilles Defraene is a leading clinical researcher in radiation oncology, with a primary focus on stereotactic body radiotherapy (SBRT) for metastatic disease. His most cited work, a 2020 study on stereotactic robotic body radiotherapy for patients with oligorecurrent pulmonary metastases, has garnered 23 citations and established foundational insights into treatment efficacy and toxicity for this challenging patient population. Defraene’s research systematically evaluates how tumor characteristics, patient-specific factors, and treatment parameters influence local control and outcomes, advancing personalized approaches in SBRT. His contributions are particularly impactful in refining CyberKnife-based robotic radiotherapy protocols, helping to define optimal dosing and delivery strategies for lung metastases. By integrating rigorous clinical data with technical precision, Defraene has improved the therapeutic ratio for oligorecurrent disease, offering patients a non-invasive option with manageable toxicity. His work continues to shape evidence-based guidelines in stereotactic body radiotherapy, making him a respected voice in the field of radiation oncology and a key figure for researchers and clinicians seeking to optimize metastatic cancer care.
Research Focus
Key Achievements
Top Papers
- 1